Cardiovascular disease in diabetes, beyond glucose

被引:117
|
作者
Eckel, Robert H. [1 ,2 ]
Bornfeldt, Karin E. [3 ,4 ]
Goldberg, Ira J. [5 ]
机构
[1] Univ Colorado, Div Endocrinol Metab & Diabet, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[2] Univ Colorado, Div Cardiol, Sch Med, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA 98195 USA
[4] Univ Washington, Dept Lab Med & Pathol, Med Diabet Inst, Seattle, WA 98195 USA
[5] NYU, Div Endocrinol Diabet & Metab, Grossman Sch Med, New York, NY USA
关键词
CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; PRESSURE-LOWERING TREATMENT; INTENSIVE GLYCEMIC CONTROL; IMPAIRED FASTING GLUCOSE; SYSTOLIC BLOOD-PRESSURE; ALL-CAUSE MORTALITY; 10-YEAR FOLLOW-UP; INSULIN-RESISTANCE; RISK-FACTORS;
D O I
10.1016/j.cmet.2021.07.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Despite the decades-old knowledge that diabetes mellitus is a major risk factor for cardiovascular disease, the reasons for this association are only partially understood. While this association is true for both type 1 and type 2 diabetes, different pathophysiological processes may be responsible. Lipids and other risk factors are indeed important, whereas the role of glucose is less clear. This lack of clarity stems from clinical trials that do not unambiguously show that intensive glycemic control reduces cardiovascular events. Animal models have provided mechanisms that link diabetes to increased atherosclerosis, and evidence consistent with the importance of factors beyond hyperglycemia has emerged. We review clinical, pathological, and animal studies exploring the pathogenesis of atherosclerosis in humans living with diabetes and in mouse models of diabetes. An increased effort to identify risk factors beyond glucose is now needed to prevent the increased cardiovascular disease risk associated with diabetes.
引用
收藏
页码:1519 / 1545
页数:27
相关论文
共 50 条
  • [21] Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?
    Canpolat, Nur
    Caliskan, Salim
    Sever, Lale
    Guzeltas, Alper
    Kantarci, Fatih
    Candan, Cengiz
    Civilibal, Mahmut
    Kasapcopur, Ozgur
    Arisoy, Nil
    PEDIATRIC NEPHROLOGY, 2012, 27 (04) : 627 - 635
  • [22] Type 2 diabetes and cardiovascular disease in South Asians
    Gholap, Nitin
    Davies, Melanie
    Patel, Kiran
    Sattar, Naveed
    Khunti, Kamlesh
    PRIMARY CARE DIABETES, 2011, 5 (01) : 45 - 56
  • [23] Nut Consumption in Relation to Cardiovascular Disease Incidence and Mortality Among Patients With Diabetes Mellitus
    Liu, Gang
    Guasch-Ferre, Marta
    Hu, Yang
    Li, Yanping
    Hu, Frank B.
    Rimm, Eric B.
    Manson, JoAnn E.
    Rexrode, Kathryn M.
    Sun, Qi
    CIRCULATION RESEARCH, 2019, 124 (06) : 920 - 929
  • [24] Subclinical atherosclerosis burden predicts cardiovascular events in individuals with diabetes and chronic kidney disease
    Palanca, Ana
    Castelblanco, Esmeralda
    Betriu, Angels
    Perpinan, Hector
    Soldevila, Berta
    Manuel Valdivielso, Jose
    Bermudez-Lopez, Marcelino
    Puig-Jove, Carlos
    Puig-Domingo, Manel
    Groop, Per-Henrik
    Fernandez, Elvira
    Alonso, Nuria
    Mauricio, Didac
    CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
  • [25] Intensive Glucose Lowering and Cardiovascular Disease Prevention in Diabetes Reconciling the Recent Clinical Trial Data
    Mazzone, Theodore
    CIRCULATION, 2010, 122 (21) : 2201 - 2211
  • [26] Diabetes, Cardiovascular Disease, and Cardiovascular Risk in Patients with Chronic Kidney Disease
    De Lima, Jose J. G.
    Gowdak, Luis Henrique W.
    David-Neto, Elias
    Bortolotto, Luiz A.
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (02) : 159 - 165
  • [27] Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance
    Laakso, M
    Lehto, S
    ATHEROSCLEROSIS, 1998, 137 : S65 - S73
  • [28] Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes
    Kelly, Tanika N.
    Bazzano, Lydia A.
    Fonseca, Vivian A.
    Thethi, Tina K.
    Reynolds, Kristi
    He, Jiang
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (06) : 394 - W130
  • [29] Cardiovascular endocrinology 1 - Aldosterone function in diabetes mellitus: Effects on cardiovascular and renal disease
    McFarlane, SI
    Sowers, JR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (02): : 516 - 523
  • [30] Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis
    Ahmad, Abrar
    Lim, Lee-Ling
    Morieri, Mario Luca
    Tam, Claudia Ha-ting
    Cheng, Feifei
    Chikowore, Tinashe
    Dudenhoffer-Pfeifer, Monika
    Fitipaldi, Hugo
    Huang, Chuiguo
    Kanbour, Sarah
    Sarkar, Sudipa
    Koivula, Robert Wilhelm
    Motala, Ayesha A.
    Tye, Sok Cin
    Yu, Gechang
    Zhang, Yingchai
    Provenzano, Michele
    Sherifali, Diana
    de Souza, Russell J.
    Tobias, Deirdre Kay
    Gomez, Maria F.
    Ma, Ronald C. W.
    Mathioudakis, Nestoras
    COMMUNICATIONS MEDICINE, 2024, 4 (01):